Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gastrointestinal Neoplasms × vandetanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 22 Neoplasm Metastasis 12 Lung Neoplasms 12 Carcinoma, Medullary 12 Thyroid Neoplasms 8 Neoplasms 7 Breast Neoplasms 7 Glioma 5 Glioblastoma 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Gliosarcoma 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Thyroid Cancer, Papillary 2 Recurrence 2 Kidney Neoplasms 2 Familial medullary thyroid carcinoma 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Disease Progression 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Biliary Tract Neoplasms 2 Adenocarcinoma, Follicular 2

Interventions

Oxaliplatin 25 Fluorouracil 22 Leucovorin 19 Irinotecan 15 Capecitabine 15 Bevacizumab 12 Surveys and Questionnaires 11 Cisplatin 11 Gemcitabine 9 Drug Therapy 9 Standard of Care 7 S 1 (combination) 6 Nivolumab 6 Cetuximab 6 pembrolizumab 5 atezolizumab 5 Endoscopic Mucosal Resection 5 Educational Status 5 Cyclophosphamide 5 Radiosurgery 4 Everolimus 4 Docetaxel 4 130-nm albumin-bound paclitaxel 4 tegafur-gimeracil-oteracil 3 sodium thiosulfate 3 pemigatinib 3 fludarabine 3 encorafenib 3 cobimetinib 3 apatinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02013089 2016-08-30

GITIC

Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡